Evidence map›Paper›PMID 19789301›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2009

UVR exposure sensitizes keratinocytes to DNA adduct formation.

Sudhir Nair, Vikram D Kekatpure, Benjamin L Judson, Arleen B Rifkind, Richard D Granstein, Jay O Boyle, Kotha Subbaramaiah, Joseph B Guttenplan, Andrew J Dannenberg

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. CYP1B1 as a therapeutic target in cardio-oncology.Clinical science (London, England : 1979) · 2020
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. FICZ: A Messenger of Light in Human Skin.The Journal of investigative dermatology · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sudhir NairDepartment of Medicine and Weill Cornell Cancer Center, 525 East 68th Street, Room F-206, New York, NY 10065, USA.
Vikram D Kekatpure
Benjamin L Judson
Arleen B Rifkind
Richard D Granstein
Jay O Boyle
Kotha Subbaramaiah
Joseph B Guttenplan
Andrew J Dannenberg
New York University · USMemorial Sloan Kettering Cancer Center · USCornell University · US

Funding

ARACHIDONATE PRODUCTS IN DIOXIN &PCB TOXICITYR01ES003606 · NIEHS · WEILL MEDICAL COLL OF CORNELL UNIV · PI RIFKIND, ARLEEN B. · 1985 to 2011
$4.8M
HEAD AND NECK TRAINING PROGRAM SURGICAL ONCOLOGYT32CA009685 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FAGIN, JAMES A, WONG, RICHARD J · 1992 to 2022
$3.6M
NCI NIH HHS T32 CA009685NCI NIH HHS T32 CA09685NIEHS NIH HHS ES03606NIEHS NIH HHS R01 ES003606
6 · The paper itself

Abstract

UV radiation (UVR) and exposure to tobacco smoke, a source of polycyclic aromatic hydrocarbons (PAH), have been linked to skin carcinogenesis. UVR-mediated activation of the aryl hydrocarbon receptor (AhR) stimulates the transcription of CYP1A1 and CYP1B1, which encode proteins that convert PAH to genotoxic metabolites. We determined whether UVR exposure sensitized human keratinocytes to PAH-induced DNA adduct formation. UVR exposure induced CYP1A1 and CYP1B1 in HaCaT cells, an effect that was mimicked by photooxidized tryptophan (aTRP) and FICZ, a component of aTRP. UVR exposure or pretreatment with aTRP or FICZ also sensitized cells to benzo(a)pyrene (B[a]P)-induced DNA adduct formation. alphaNF, an AhR antagonist, suppressed UVR-, aTRP-, and FICZ-mediated induction of CYP1A1 and CYP1B1 and inhibited B[a]P-induced DNA adduct formation. Treatment with 17-AAG, an Hsp90 inhibitor, caused a marked decrease in levels of AhR; inhibited UVR-, aTRP-, and FICZ-mediated induction of CYP1A1 and CYP1B1; and blocked the sensitization of HaCaT cells to B[a]P-induced DNA adduct formation. FICZ has been suggested to be a physiologic ligand of the AhR that may have systemic effects. Hence, studies of FICZ were also carried out in MSK-Leuk1 cells, a model of oral leukoplakia. Pretreatment with alpha-naphthoflavone or 17-AAG blocked FICZ-mediated induction of CYP1A1 and CYP1B1, and suppressed the increased B[a]P-induced DNA adduct formation. Collectively, these results suggest that sunlight may activate AhR signaling and thereby sensitize cells to PAH-mediated DNA adduct formation. Antagonists of AhR signaling may have a role in the chemoprevention of photocarcinogenesis.

Indexed as

Aryl Hydrocarbon HydroxylasesCell LineCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DNA AdductsHumansKeratinocytesPolycyclic Aromatic HydrocarbonsReceptors, Aryl HydrocarbonSignal TransductionTranscription, GeneticUltraviolet RaysAryl Hydrocarbon HydroxylasesCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DNA AdductsPolycyclic Aromatic Hydrocarbonspolycyclic aromatic hydrocarbons-DNA adductReceptors, Aryl Hydrocarbon

Identifiers

PMID19789301
PMCPMC2758323
OpenAlexW2102784873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.